Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients

MERSİN S., GEDÜK A., MEHTAP Ö., TARKUN P., ÜNAL S., POLAT M. G., ...Daha Fazla

TURKISH JOURNAL OF HEMATOLOGY, cilt.38, sa.3, ss.211-217, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4274/tjh.galenos.2021.2020.0555
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.211-217
  • Anahtar Kelimeler: Bortezomib, Multiple myeloma, Equivalent, CYCLOPHOSPHAMIDE, DEXAMETHASONE, COMBINATION, EFFICACY
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Objective: Constantly increasing health expenditures lead to the use of generic molecules and generic versions of bortezomib have been used for a long time. The aim of this study is to retrospectively examine the effectiveness, side effects, and reliability of generic bortezomib in newly diagnosed multiple myeloma (MM) patients.